All Deepbridge Capital LLP articles
-
NewsMicroplate DX secures £2.5m to develop rapid diagnostic technology that confirms presence of bacteria
Microplate Dx has closed a £2.5M seed funding round to develop its point-of-care diagnostic platform which can guide a patient’s doctor to effective treatment by identifying effective antibiotics to use and which to avoid.
